FDA to Congress: More Work May Be Needed to Discourage Anticompetitive Citizen Petitions

Drug Industry Daily
A A
The FDA is concerned that legislative provisions designed to discourage citizen petition abuse may not be doing enough.

To View This Article:

Login

Subscribe To Drug Industry Daily